STERIS CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-12-10: Form 8-K; Period of report 2014-12-10; Description 8.01 Other Events; Details 8.01.
- 2014-11-26: Form 8-K; Period of report 2014-11-25; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; Details 5.02.
- 2014-11-04: Form 8-K; Period of report 2014-11-04; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2014-10-14: Form 8-K; Period of report 2014-10-13; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 8.01 Other Events; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2014-12-10 | 8-K | 2014-12-10 | 8.01 Other Events | 8.01 On December 8, 2014, STERIS Corporation (“STERIS”) voluntarily withdrew its Notification and Report Form, filed with the Federal Trade Commission (the “FTC”) and the Antitrust Division of the United States Department of Justice (“DOJ”) pursuant to the Hart-Scott Rodino Antitrust Improvements Act of 1976, and re-filed the Notification and Report Form with the FTC and DOJ on December 10, 2014. | d833951d8k.htm |
| 2014-11-26 | 8-K | 2014-11-25 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 In connection with the proposed transactions previously announced by STERIS Corporation (“STERIS”) which, if completed, will result in both STERIS and Synergy Health plc becoming direct or indirect wholly-owned subsidiaries of a newly formed U.K. corporation (the “Combination”), STERIS has adopted a compensatory arrangement intended to provide “make-whole” payments to its executive officers and directors who will be subject to a 15% excise tax imposed under Section 4985 of the Internal Revenue Code of 1986, as amended, on their outstanding stock options, restricted stock and career restricted stock units, solely because of the closing of the Combination. 8.01 On November 26, 2014, New STERIS filed with the SEC the Registration Statement, which includes a preliminary proxy statement of STERIS and also constitutes a preliminary prospectus of New STERIS. | d826722d8k.htm |
| 2014-11-04 | 8-K | 2014-11-04 | 2.02 Results of Operations and Financial Condition | 2.02 On November 4, 2014, STERIS issued a press release announcing financial results for its fiscal 2015 second quarter ended September 30, 2014. | d815461d8k.htm |
| 2014-10-14 | 8-K | 2014-10-13 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 8.01 Other Events | 1.01 On October 13, 2014, STERIS Corporation (“STERIS”) and Synergy Health plc, a public company organized under the laws of England and Wales (“Synergy”), issued an announcement under Rule 2.7 of the United Kingdom City Code on Takeovers and Mergers (the “Rule 2.7 Announcement”) stating that Solar New HoldCo Limited, a private limited company organized under the laws of England and Wales and a subsidiary of STERIS (“New STERIS”), is commencing a “recommended offer” under English law to acquire Synergy (the “Combination”). 2.03 On October 13, 2014, STERIS entered into the Bridge Credit Agreement as described under Item 1.01 above. 8.01 On October 13, 2014, in connection with the announcement of the Combination, the Company issued a press release, provided supplemental information regarding the proposed transaction in presentations to analysts and investors, and distributed a “frequently asked questions” document to employees. | d804033d8k.htm |
| 2014-08-05 | 8-K | 2014-07-30 | 2.02 Results of Operations and Financial Condition; 5.07 Submission of Matters to a Vote of Security Holders | 2.02 On August 5, 2014, STERIS Corporation (“STERIS” or “Company”) issued a press release announcing financial results for its fiscal 2015 first quarter ended June 30, 2014. 5.07 At the STERIS 2014 Annual Meeting of Shareholders (“Meeting”), held on July 30, 2014, shareholders voted on the matters specified below, with the final voting results as specified. | d767721d8k.htm |
| 2014-05-09 | 8-K | 2014-05-09 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On May 9, 2014, STERIS Corporation (“STERIS”) completed the previously announced acquisition of all of the outstanding shares of capital stock of Integrated Medical Systems International, Inc. (“IMS”) pursuant to that certain Stock Purchase Agreement (the “Stock Purchase Agreement”) dated March 31, 2014 with IMS and its shareholders. | d723190d8k.htm |
| 2014-05-08 | 8-K | 2014-05-08 | 2.02 Results of Operations and Financial Condition | 2.02 On May 8, 2014, STERIS Corporation issued a press release announcing financial results for the three and twelve month periods ended March 31, 2014. | d721656d8k.htm |
| 2014-04-02 | 8-K | 2014-03-31 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 On April 1, 2014, STERIS issued a press release announcing the signing of the Stock Purchase Agreement. | d704320d8k.htm |
| 2014-03-26 | 8-K | 2014-03-26 | 2.05 Costs Associated with Exit or Disposal Activities; 2.06 Material Impairments; 8.01 Other Events | 8.01 On March 26, 2014, STERIS Corporation (the “Company”) issued a press release announcing a targeted restructuring plan. | d699769d8k.htm |
| 2014-02-05 | 8-K | 2014-02-05 | 2.02 Results of Operations and Financial Condition | 2.02 On February 5, 2014, STERIS Corporation issued a press release announcing financial results for its fiscal 2014 third quarter ended December 31, 2013. | d670961d8k.htm |
| 2014-01-14 | 8-K | 2014-01-13 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 STERIS Corporation (“Company”) and Timothy L. Chapman, its Senior Vice President and Group President, Healthcare (“Executive”), have agreed that Executive will begin a personal leave of absence on January 13, 2014. | d658394d8k.htm |